In Vitro and In Vivo Assessment of Linezolid Combined with Ertapenem: a Highly Synergistic Combination against Methicillin-Resistant Staphylococcus aureus
暂无分享,去创建一个
E. Batard | J. Caillon | G. Potel | C. Jacqueline | D. Bugnon | A. Miègeville | O. Grossi | V. Le Mabecque
[1] D. Hoban,et al. Ertapenem: review of a new carbapenem , 2005, Expert review of anti-infective therapy.
[2] E. Batard,et al. In Vitro and In Vivo Synergistic Activities of Linezolid Combined with Subinhibitory Concentrations of Imipenem against Methicillin-Resistant Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.
[3] V. Lorian. Antibiotics in laboratory medicine , 2005 .
[4] E. Batard,et al. In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. , 2004, International journal of antimicrobial agents.
[5] John S. Bradley,et al. Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy , 2004 .
[6] P. Deutsch,et al. Pharmacokinetics of Total and Unbound Ertapenem in Healthy Elderly Subjects , 2004, Antimicrobial Agents and Chemotherapy.
[7] Fu-Yu Chiang,et al. Efficacy of Linezolid Alone or in Combination with Vancomycin for Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus , 2003, Antimicrobial Agents and Chemotherapy.
[8] J. K. Gibson,et al. Efficacy of Linezolid plus Rifampin in an Experimental Model of Methicillin-Susceptible Staphylococcus aureus Endocarditis , 2003, Antimicrobial Agents and Chemotherapy.
[9] E. Batard,et al. In Vivo Efficacy of Continuous Infusion versus Intermittent Dosing of Linezolid Compared to Vancomycin in a Methicillin-Resistant Staphylococcus aureus Rabbit Endocarditis Model , 2002, Antimicrobial Agents and Chemotherapy.
[10] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[11] N. Ozawa,et al. Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography. , 1999, Journal of pharmaceutical and biomedical analysis.
[12] D. Musson,et al. High-performance liquid chromatographic methods for the determination of a new carbapenem antibiotic, L-749,345, in human plasma and urine. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[13] J. Caillon,et al. In vivo simulation of human pharmacokinetics in the rabbit , 1998, Bulletin of mathematical biology.
[14] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .
[15] J. Caillon,et al. Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method. , 1987, The Journal of antimicrobial chemotherapy.
[16] R. Pearson,et al. Method of reliable determination of minimal lethal antibiotic concentrations , 1980, Antimicrobial Agents and Chemotherapy.
[17] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[18] R. Rucker,et al. Outpatient intravenous medications in the management of cystic fibrosis. , 1974, Pediatrics.
[19] D. Durack,et al. Experimental Bacterial Endocarditis: II. Survival of Bacteria in Endocardial Vegetations , 1972 .
[20] B. Perlman,et al. Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. , 1971, The Yale journal of biology and medicine.
[21] L. Garrod,et al. Methods of testing combined antibiotic bactericidal action and the significance of the results , 1962, Journal of clinical pathology.